143 related articles for article (PubMed ID: 15544589)
1. Comparison of a generic and a rhinitis-specific quality-of-life (QOL) instrument in patients with house dust mite allergy: relationship between the SF-36 and Rhinitis QOL Questionnaire.
Terreehorst I; Duivenvoorden HJ; Tempels-Pavlica Z; Oosting AJ; de Monchy JG; Bruijnzeel-Koomen CA; Gerth van Wijk R
Clin Exp Allergy; 2004 Nov; 34(11):1673-7. PubMed ID: 15544589
[TBL] [Abstract][Full Text] [Related]
2. Why generic and disease-specific quality-of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitis.
Leong KP; Yeak SC; Saurajen AS; Mok PK; Earnest A; Siow JK; Chee NW; Yeo SB; Khoo ML; Lee JC; Seshadri R; Chan SP; Tang CY; Chng HH
Clin Exp Allergy; 2005 Mar; 35(3):288-98. PubMed ID: 15784105
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires.
Petersen KD; Kronborg C; Gyrd-Hansen D; Dahl R; Larsen JN; Løwenstein H
Allergy; 2008 Mar; 63(3):284-91. PubMed ID: 18269674
[TBL] [Abstract][Full Text] [Related]
4. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms.
Mosbech H; Canonica GW; Backer V; de Blay F; Klimek L; Broge L; Ljørring C
Ann Allergy Asthma Immunol; 2015 Feb; 114(2):134-40. PubMed ID: 25624131
[TBL] [Abstract][Full Text] [Related]
5. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis.
Walter Canonica G; Bousquet J; Van Hammée G; Bachert C; Durham SR; Klimek L; Mullol J; Van Cauwenberge PB;
Respir Med; 2006 Oct; 100(10):1706-15. PubMed ID: 16723217
[TBL] [Abstract][Full Text] [Related]
6. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis.
Terreehorst I; Duivenvoorden HJ; Tempels-Pavlica Z; Oosting AJ; de Monchy JG; Bruijnzeel-Koomen CA; van Wijk RG
Allergy; 2005 Jul; 60(7):888-93. PubMed ID: 15932378
[TBL] [Abstract][Full Text] [Related]
7. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters.
Pasquali M; Baiardini I; Rogkakou A; Riccio AM; Gamalero C; Descalzi D; Folli C; Passalacqua G; Canonica GW
Clin Exp Allergy; 2006 Sep; 36(9):1161-7. PubMed ID: 16961716
[TBL] [Abstract][Full Text] [Related]
8. Treatment of chronic rhinitis by an allergy specialist improves quality of life outcomes.
Bagenstose SE; Bernstein JA
Ann Allergy Asthma Immunol; 1999 Dec; 83(6 Pt 1):524-8. PubMed ID: 10619343
[TBL] [Abstract][Full Text] [Related]
9. Atopy patch testing in children with asthma and rhinitis symptoms allergic to house dust mite.
Guler N; Kirerleri E; Tamay Z; Ones U
Pediatr Allergy Immunol; 2006 Aug; 17(5):346-50. PubMed ID: 16846452
[TBL] [Abstract][Full Text] [Related]
10. Perceived control and quality of life in asthma: impact of asthma education.
Olajos-Clow J; Costello E; Lougheed MD
J Asthma; 2005 Nov; 42(9):751-6. PubMed ID: 16316869
[TBL] [Abstract][Full Text] [Related]
11. Quality of life assessment in Thai patients with allergic rhinoconjunctivitis using the SF-36 questionnaire (Thai version).
Bunnag C; Leurmarnkul W; Jareoncharsri P; Tunsuriyawong P; Assanasen P; Pawankar R
Rhinology; 2005 Jun; 43(2):99-103. PubMed ID: 16008063
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of quality of life questionnaires for adult patients with moderate to severe allergic rhinitis.
Lu D; Zhao Y; Zheng Y; An P; Wang L; Qiao X; Wang D
Am J Otolaryngol; 2011; 32(6):494-8. PubMed ID: 21094561
[TBL] [Abstract][Full Text] [Related]
13. [Correlation between the SF-8 health status questionnaire and JRQLQ in patients with Japanese cedar pollinosis].
Fujii T; Ogino S; Arimoto H; Irifune M; Iwata N; Ookawachi I; Kikumori H; Seo R; Takeda M; Tamaki A; Baba K; Nose M
Arerugi; 2007 Feb; 56(2):109-17. PubMed ID: 17347597
[TBL] [Abstract][Full Text] [Related]
14. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
15. [Quality of life in patients with perennial allergic rhinitis: using the Japanese version of the SF-36 Health Status Questionnaire].
Fukuroku K; Ogino S
Arerugi; 2001 Apr; 50(4):385-93. PubMed ID: 11398335
[TBL] [Abstract][Full Text] [Related]
16. Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patients.
Laforest L; Bousquet J; Neukirch F; Aubier M; Pietri G; Devouassoux G; Pacheco Y; Van Ganse E
Ann Allergy Asthma Immunol; 2005 Jul; 95(1):26-32. PubMed ID: 16095138
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis.
Zhang L; Wang C; Han D; Wang X; Zhao Y; Liu J
Int Arch Allergy Immunol; 2009; 148(2):161-9. PubMed ID: 18802361
[TBL] [Abstract][Full Text] [Related]
18. Skin tests, T cell responses and self-reported symptoms in children with allergic rhinitis and asthma due to house dust mite allergy.
Moed H; van Wijk RG; de Jongste JC; van der Wouden JC
Clin Exp Allergy; 2009 Feb; 39(2):222-7. PubMed ID: 19032359
[TBL] [Abstract][Full Text] [Related]
19. [Comparison of PedsQL™4.0 and RQLQ scales in the assessment of the quality of life in children with allergic rhinitis].
Zhang YT; Zhang X; Li PZ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(1):27-29. PubMed ID: 29774680
[No Abstract] [Full Text] [Related]
20. Development and validation of a new Spanish instrument to measure health-related quality of life in patients with allergic rhinitis: the ESPRINT questionnaire.
; Valero A; Alonso J; Antepara I; Baró E; Colas C; del Cuvillo A; Ferrer M; Herdman M; Martí-Guadaño E; Monclús L; Mullol J; Navarro-Pulido AM; Navas C; Sastre J; Baltasar M; Bartra J; Serrano C; Cardona V; Castillo JA; Cerda MT; Cistero A; Conejero A; Davila I; Escudero C; Hernandez E; Vereda A; Fernandez B; Mencia J; Fernández J; Florido J; Quiralte J; Guardia P; Malek T; Montoro J; Orta JC; Oehling A; Pascual MJ; de la Parte B; Raga E; Rubira N; Ranea S; Rivas P; Serra J; Tabar A
Value Health; 2007; 10(6):466-77. PubMed ID: 17970929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
